Search

everythinglearnresearchcommunity

for

Search:↓

Cetuximab can cause excessive eyelash growth.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

Forming spheres boosts the ability of certain human cells to create hair follicles when mixed with mouse skin cells.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Both mouse and rat models are effective for testing alopecia areata treatments.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Stem cell niches are adaptable and key for tissue maintenance and repair.